Important differences in components of the metabolic syndrome between HIV-patients with and without highly active antiretroviral therapy and healthy controls-Reference-Cited by-同舟云学术

Important differences in components of the metabolic syndrome between HIV-patients with and without highly active antiretroviral therapy and healthy controls

Published:2006-01 Issue:8 Volume:38 Page:682-689
ISSN:0036-5548
Container-title:Scandinavian Journal of Infectious Diseases
language:en
Short-container-title:Scandinavian Journal of Infectious Diseases

Author:

Magny Bergersen Bente¹,Schumacher Anita²,Sandvik Leiv³,Bruun Johan N.⁴,Birkeland Kåre⁵

Affiliation:

1. From the Department of Infectious Diseases, Aker University Hospital, Oslo

2. Department of Internal Medicine, Hospital of Vestfold, Tønsberg

3. Centre for Clinical Research, Ullevål University Hospital, Oslo

4. Department of Infectious Diseases, Ulleval University Hospital,

5. Hormone Laboratory, Aker University Hospital and Faculty Division, Aker University Hospital, University of Oslo, Oslo, Norway

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365540500361302

Reference25 articles.

1. Insulin resistance in the HIV-lipodystrophy syndrome

2. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance

3. Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome

4. Combination Antiretroviral Therapy and the Risk of Myocardial Infarction

5. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High prevalence of low high‐density lipoprotein cholesterol and insulin resistance among children and adolescents living with HIV in Uganda: harbinger for metabolic syndrome?;HIV Medicine;2023-10-25

2. Defining the optimum HOMA-IR cut-off value for insulin resistance among ARV-treated HIV patients in Indonesia;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2023-02

3. High prevalence of low high-density lipoprotein cholesterol and insulin resistance among children and adolescents living with HIV in Uganda: Harbinger for metabolic syndrome?;2022-12-03

4. HIV-1 Spectrum Disease, Psychological Distress, and Cardiometabolic Risk;Handbook of Cardiovascular Behavioral Medicine;2022

5. Association of HIV infection with metabolic syndrome among normal or underweight young adults: evidence from the CHART cohort;BioScience Trends;2020-12-31